Conclusively, PPARγ is closely associated with the occurrence, development, proliferation, and prognosis of colorectal cancer and may become a novel molecular biomarker for clinical staging of colorectal cancer and a promising therapeutic target for colorectal cancer. Here, PPARG is linked to colorectal cancer.